AlphaCentric Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$242K Buy
821
+47
+6% +$14K 0.24% 131
2025
Q4
$211K Buy
+774
New +$210K 0.21% 138
2024
Q4
$194K Sell
837
-20
-2% -$4.6K 0.19% 120
2024
Q3
$189K Sell
857
-61
-7% -$12.6K 0.14% 139
2024
Q2
$180K Buy
918
+13
+1% +$2.69K 0.13% 130
2024
Q1
$195K Sell
905
-62
-6% -$13K 0.12% 133
2023
Q4
$204K Buy
+967
New +$206K 0.14% 111

Other funds holding CME

AlphaCentric Advisors's CME Position: Q1 2026 in Review

AlphaCentric Advisors increased its CME Group (CME) stake by 6.1% in Q1 2026, buying an estimated $14K and bringing the position to 821 shares worth $242K. The position accounts for 0.24% of the portfolio, ranked #131.

AlphaCentric Advisors first reported a position in CME in Q4 2023 and has held it in 7 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • AlphaCentric Advisors held 821 shares of CME Group worth $242K as of Q1 2026.
  • AlphaCentric Advisors bought 47 CME Group shares in Q1 2026, an estimated $14K.
  • CME Group made up 0.24% of AlphaCentric Advisors's portfolio in Q1 2026, its #131 holding.
  • AlphaCentric Advisors first reported a position in CME Group in Q4 2023 and has held it in 7 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.